SCHEMBL3132248

SCHEMBL3132248

NC(=O)C[C@H](NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(N)=O

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TRHR P34981 6/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14185753 1.00 TRHR (0.68) TRHR
SCHEMBL14185750 0.91 TRHR (0.57) TRHR
SCHEMBL14185774 0.90 TRHR (0.55) TRHR
SCHEMBL31332262 0.90 TRHR (0.66) TRHR
SCHEMBL14185746 0.88 TRHR (0.55) TRHR
SCHEMBL14185751 0.88 TRHR (0.57) TRHR
SCHEMBL11182741 0.88 TRHR (0.66) TRHR
SCHEMBL11331704 0.88 TRHR (0.66) TRHR
SCHEMBL1371608 0.88 TRHR (0.66) TRHR
SCHEMBL11327973 0.88 TRHR (0.66) TRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794182-B1 COMPOUNDS THAT MODULATE TRH ACTIONS AND INHIBIT THE TRH-DEGRADING ENZYME TRINITY COLLEGE DUBLIN (IE) 2015-06-03 — — EP disclosed
EP-1261624-B1 TRH-LIKE PEPTIDE DERIVATIVES AS INHIBITORS OF THE TRH-DEGRADING ECTOENZYME TRINITY COLLEGE DUBLIN (IE) 2010-07-07 — — EP disclosed
US-7378397-B2 TRH-degrading ectoenzyme inhibitors THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2008-05-27 — — US disclosed
US-20060293247-A1 TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen 2006-12-28 — — US disclosed
US-20030166944-A1 TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF TH HOLY 2003-09-04 — — US disclosed
EP-1261624-A1 TRH-LIKE PEPTIDE DERIVATIVES AS INHIBITORS OF THE TRH-DEGRADING ECTOENZYME The Provost, Fellows and Scholars of the College of the Holy and Undivide Trinity of Queen Elisabeth near Dublin (IE) 2002-12-04 — — EP disclosed
WO-2001060843-A1 TRH-LIKE PEPTIDE DERIVATIVES AS INHIBITORS OF THE TRH-DEGRADING ECTOENZYME THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2001-08-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166944-A1 TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme TRHDE, TRHR, TSHR TRHR 2/4885
US-20060293247-A1 TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme TRHR, TRHDE, TSHR TRHR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback